Public Documents

Personal Injury

All Categories

 
Public Documents - Personal Injury

Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 201
Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 2013 Federal Court NuvaRing MDL Bellwether Trial Dates Pushed Back Several Times Previously; Perhaps It Will Be Late 2012 http://www.drug-injury.com/druginjurycom/2012/03/nuvaring-new-jersey-trial-dates-federal-court-mdl-bellwether-cases-judges-sippel-martinotti.html
Posted by Tom Lamb on 3.13.12 in Personal Injury.
Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects
Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects Prescriber Error, Impaired Renal Function, Patient Age, And Lack Of An Effective Reversal Agent Are Cited http://www.drug-injury.com/druginjurycom/2012/03/pradaxa-bleeding-risk-factors-age-renal-function-prescriber-error-no-reversal-agent.html
Posted by Tom Lamb on 3.8.12 in Personal Injury.
Yasmin / YAZ Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012
Yasmin / YAZ Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012 Bayer 2011 Annual Report: Settlement Agreements: 70 Cases Settled As of Mid-February 2012; Negotiations Will Continue On Case-by-Case Basis http://www.drug-injury.com/druginjurycom/2012/02/yasmin-yaz-settlements-bayer-lawsuits-mdl-mediation-cases-number-update-2012.html
Posted by Tom Lamb on 2.29.12 in Personal Injury.
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills Same General Warning About All COCs Was Added To YAZ In March 2011; And Why The One Year Delay, We Wonder Bayer, Beyaz, birth control pills, drospirenone, DRSP, FDA, label change, oral contraceptives, package insert, Safyral, warnings precautions, Yasmin, YAZ
Posted by Tom Lamb on 2.20.12 in Personal Injury.
Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings
Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings At Increased Risk Are Patients Who Are Older, Have Altered Renal Clearance, Or Undergoing Atrial Fibrillation (AF) Ablation http://www.drug-injury.com/druginjurycom/2012/02/pradaxa-bleeding-events-elderly-older-renal-clearance-kidney-function-af-ablation.html
Posted by Tom Lamb on 2.13.12 in Personal Injury.
Gianvi Lawsuits Against The Drug Companies Still Possible After 2011 Supreme Court Preemption Ruling
Gianvi Lawsuits Against The Drug Companies Still Possible After 2011 Supreme Court Preemption Ruling Re: Generic Drug Injury Lawsuits Reason Is That Bayer Has Been Supplying Teva And Barr With The Product For Their Gianvi Pills Since December 2010 (Agreement Is Similar To Ocella Deal) http://www.drug-injury.com/druginjurycom/2012/02/gianvi-generic-drug-lawsuits-injury-death-blood-clots-pe-dvt-stroke.html
Posted by Tom Lamb on 2.9.12 in Personal Injury.
Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 -- We Learn From The FDA
Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 -- We Learn From The FDA In January 2012 Significant Safety Concern": Higher Death Rate For Doribax In Ventilator-Associated Pneumonia When Compared To Patients Receiving Imipenem Therapy http://www.drug-injury.com/druginjurycom/2012/01/doribax-safety-issue-increased-risk-death-pneumonia-ventilator-patients-fda-ema-janssen.html
Posted by Tom Lamb on 1.31.12 in Personal Injury.
YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting N
YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More) 11 Of The 26 FDA Panel Members Voted There Were No Sufficient Unique Benefits For YAZ / Yasmin That Cannot Be Found In Other Hormonal Contraceptives http://www.drug-injury.com/druginjurycom/2012/01/yaz-yasmin-update-2012-fda-advisory-panel-members-voting-conflicts-of-interest-drsp-safety-issue.html
Posted by Tom Lamb on 1.24.12 in Personal Injury.
Safety Profile Of New Stroke Drug Has Been Tarnished By Various Adverse Event Reports
Safety Profile Of New Stroke Drug Has Been Tarnished By Various Adverse Event Reports FDA Reviewing Serious Side Effects Associated With Pradaxa Ranging From Heart Attacks To Serious Bleeding or Hemorrhages http://www.drug-injury.com/druginjurycom/2012/01/pradaxa-side-effects-heart-attacks-hemorrhages-serious-bleeding-fda-review-safety.html
Posted by Tom Lamb on 1.18.12 in Personal Injury.
Prescription Drug Medication Errors Can Be Prevented By Taking Some Common Sense Precautions
Prescription Drug Medication Errors Can Be Prevented By Taking Some Common Sense Precautions Ten Strategies Intended For Pharmacists Can Help Patients Stay Safe, Also http://www.drug-injury.com/druginjurycom/2012/01/medication-errors-due-pharmacy-dispensing-mistakes-prevention-pointers-tips-pharmacists-patients.html
Posted by Tom Lamb on 1.6.12 in Personal Injury.